Bioanalytical assays for gene therapy programs podcast
An Interview with Catherine Vrentas
In this podcast, PPD expert Cathy Vrentas discusses how to leverage bioanalytical assays for gene therapy programs, key considerations in the development of these assays, and how the unique nature of gene therapies impact the development and maintenance of bioanalytical assays.
Speaker: Catherine (Cathy) Vrentas, senior research scientist, bioanalytical lab
Key takeaways:
- Explore types of bioanalytical assays important for gene therapy programs.
- Learn key questions regarding the design of quantitative assays for gene therapy and the unique nature of gene therapies.
- Hear key considerations inherent to the development of assays to assess levels of analytes in tissues.
Learn more about PPD Laboratories Bioanalytical Lab.